RxDoctor Payments DataLook up a doctor →

Louay Hanna, MD

Medical Oncology · Hickory, NCNPI 1427355452

Payments from drug & device makers

$61,109in general payments, 2019–2025

Across 1,305 payments — averaging $46.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$11K
  • E.r. Squibb & Sons, L.L.C.$10K
  • Lilly USA, LLC$5K
  • Johnson & Johnson$4K
  • Exelixis Inc.$4K
  • Novartis$2K
  • plus $24K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)88$11,269
E.r. Squibb & Sons, L.L.C.77$9,650
Lilly USA, LLC65$5,146
Johnson & Johnson(2 entities)59$3,967
Exelixis Inc.34$3,767
Novartis77$2,297
Amgen49$2,127
Pfizer93$1,953
Seagen Inc.29$1,932
Daiichi Sankyo Inc.28$1,721
Genmab U.S., Inc.9$1,599
Incyte Corporation27$1,476
Merck74$1,359
Genentech USA, Inc.76$1,275
Bayer16$1,224
Beigene USA, Inc.12$847
Eisai Inc.43$754
Takeda Pharmaceuticals U.S.A., Inc.41$701
Sanofi28$666
Bristol Myers Squibb30$504
Karyopharm Therapeutics Inc.19$438
Gilead(2 entities)23$412
GSK21$397
AbbVie18$320
Geron Corporation6$294
Array Biopharma Inc20$291
Jazz Pharmaceuticals Inc.12$235
AVEO Pharmaceuticals, Inc.9$214
Astellas Pharma US Inc11$195
Pharmacyclics LLC, An Abbvie Company11$182
Athenex Pharmaceutical Division, LLC1$175
Ipsen Biopharmaceuticals, Inc9$172
Regeneron Healthcare Solutions, Inc.8$166
ADC Therapeutics America, Inc.10$156
Pharmaessentia USA Corporation7$149
Beone Medicines USA, Inc.7$146
Puma Biotechnology, Inc.8$134
Boehringer Ingelheim8$130
Sobi, Inc7$129
Acrotech Biopharma Inc.6$128
Servier Pharmaceuticals LLC7$126
Myriad Genetic Laboratories, Inc.4$119
Deciphera Pharmaceuticals Inc.5$101
EMD Serono, Inc.6$95
Taiho Oncology, Inc.5$94
Coherus Oncology, Inc.3$84
Spectrum Pharmaceuticals Inc.4$79
Pharmacosmos Therapeutics Inc.4$74
Novocure Inc.3$72
Epizyme, Inc.4$72
Tempus AI, Inc3$70
Adaptive Biotechnologies Corporation4$69
Foundation Medicine, Inc.4$67
Sun Pharmaceutical Industries Inc.3$62
Teva Pharmaceuticals USA, Inc.5$62
Stemline Therapeutics Inc.3$59
Agios Pharmaceuticals, Inc.3$56
Springworks Therapeutics, Inc.3$54
Kyowa Kirin, Inc.4$54
Tersera Therapeutics LLC3$50

How this compares

$61,109 in reported general payments places this provider in the 65th percentile of 170 medical oncology providers in North Carolina.

See all medical oncology providers in North Carolina →

Medicare billing

Part B allowed, 2024
$3,141,747
Medicare patients
585
Services billed
142,326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Hickory

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →